Disease Overview：Neutropenia（NEUT）
Neutropenia is a hematologic condition characterized by an abnormally low absolute neutrophil count (ANC) — typically defined as <1,500/μL in adults, with severe neutropenia occurring at <500/μL. Neutrophils are essential effector cells in innate immunity; their deficiency significantly increases susceptibility to bacterial and fungal infections, ranging from recurrent oral ulcers and gingivitis to life-threatening sepsis or pneumonia. Causes are diverse: congenital (e.g., Kostmann syndrome, cyclic neutropenia), acquired (chemotherapy-induced, autoimmune neutropenia, HIV-associated), or idiopathic. Diagnosis relies on complete blood count (CBC) with differential, bone marrow aspiration and biopsy to assess myeloid maturation, and targeted testing for underlying etiologies such as G-CSF receptor mutations or autoantibodies. Management hinges on identifying and addressing the root cause, infection prophylaxis (e.g., fluoroquinolones, antifungals), granulocyte colony-stimulating factor (G-CSF) therapy, and, in select refractory cases, hematopoietic stem cell transplantation.
China offers distinct advantages for neutropenia care: its tertiary hospitals — particularly those affiliated with Peking University People’s Hospital and Shanghai Ruijin Hospital — house nationally recognized hematology centers with deep expertise in rare myeloid disorders and extensive experience managing complex, treatment-resistant cases. Advanced diagnostics include next-generation sequencing for genetic neutropenias and flow cytometry–based neutrophil function assays. Clinical outcomes reflect this proficiency: published cohort studies report >85% response rates to optimized G-CSF regimens and high engraftment success in transplant recipients. Crucially, comprehensive care — including diagnostics, biologics, and inpatient management — costs 40–60% less than in the US or Western Europe, without compromising evidence-based protocols or accreditation standards (JCI- or CNAS-certified facilities). As a dedicated medical tourism agency, we facilitate seamless international patient journeys: verifying physician credentials, coordinating appointments at top-tier hematologic centers, providing itemized, transparent pricing in advance, and delivering end assistance and medical translation to post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Neutropenia (Hematology Department)
Non-Surgical / Conservative / Medication-Based Management
*Target Criteria:* Mild-to-moderate neutropenia (ANC 500–1,500/μL), stable without fever or infection; drug-induced or idiopathic cases.
- •Granulocyte Colony-Stimulating Factor (G-CSF) Therapy
- *Pegfilgrastim (single 6 mg SC dose/cycle)*: $210–$285 per dose - *Monitoring*: CBC with differential ×3/week during treatment → $12–$18/test - *Baseline labs*: Comprehensive metabolic panel, vitamin B12/folate, copper/zinc, ANA, EBV/CMV PCR → $135 total
- •Infection Prophylaxis & Supportive Care
- Fluconazole (if fungal risk): $15–$22/month - IV immunoglobulin (for antibody deficiency comorbidity): $320–$490 per 20 g infusion
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Severe chronic neutropenia (ANC <500/μL for >3 months) refractory to G-CSF; suspected bone marrow failure or clonal hematopoiesis; need for definitive diagnosis or curative intent.
- •Bone Marrow Aspiration & Biopsy (BMA/B)
- Procedure (local anesthesia, bilateral iliac crest sampling): $220–$310 - Flow cytometry + cytogenetics (karyotype + FISH for del(20q), monosomy 7): $480 - Next-generation sequencing (myeloid panel): $620
- •Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
- Pre-transplant evaluation (pulmonary function, cardiac echo, PET-CT, viral serologies): $1,850 - Conditioning regimen (fludarabine/busulfan): $2,400–$3,100 - Stem cell infusion + 30-day inpatient care: $28,500–$36,800 - GVHD prophylaxis (tacrolimus + methotrexate): $390/month
Special / Complex Condition Management
- •Autoimmune Neutropenia (e.g., SLE-associated): IV methylprednisolone pulse ($110/course) + rituximab ($1,250–$1,680/dose ×4)
- •Congenital Neutropenia (e.g., ELANE mutation): Lifelong G-CSF ($2,160–$3,420/year); HSCT considered if MDS evolution ($32,000–$41,000 total)
- •Chemotherapy-Induced Febrile Neutropenia: Empiric piperacillin-tazobactam IV ×7 days ($280–$410), plus G-CSF ($210–$285)
Quick Selection Guide
- •Elderly (>75 y), mild neutropenia, limited budget: G-CSF monotherapy + oral prophylaxis → $2,300–$3,100/year
- •Young adult, severe chronic neutropenia, no donor: Extended G-CSF + BMA/B + NGS → $4,200–$5,600 initial year
- •Child with congenital neutropenia + high-risk genetics: Early allo-HSCT referral → $32,000–$41,000 (one-time)
- •Active febrile neutropenia + comorbidities (CKD, COPD): Inpatient IV antibiotics + G-CSF + supportive ICU monitoring → $4,800–$7,200/admission
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Neutropenia Medical Vacation Packages
Curated transparent all-inclusive packages combining Neutropenia treatment with China top medical destinations:
